Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2012; 18(18): 2280-2286
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2280
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2280
Fibrosis stage | n | Serum CCN2(μg/L) median (95% CI) | Hepatic CCN2 mRNA(IOD) median (95% CI) |
Normal control | 8 | 2.2 (1.5-2.9) | 6.0 (3.9-8.8) |
F1 | 11 | 6.8 (5.0-8.9) | 19.4 (12.3-26.4) |
F2 | 9 | 8.9 (7.1-10.7) | 25.6 (13.9-34.8) |
F3 | 11 | 9.4 (7.3-12.0) | 31.9 (19.7-44.6) |
F4 | 8 | 10.1 (8.2-12.1) | 39.6 (25.5-52.8) |
- Citation: Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis. World J Gastroenterol 2012; 18(18): 2280-2286
- URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2280